Generation of human bispecific common light chain antibodies by combining animal immunization and yeast display

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Protein engineering, design & selection : PEDS

• Publication date

  2017-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/protein/gzw077PMID 28062646
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Single-domain antibodies for biomedical applications

  2016cited by this paper
• Factor VIII-Mimetic Function of Humanized Bispecific Antibody in Hemophilia A.

  2016cited by this paper
• “NextGen” Biologics: Bispecific Antibodies and Emerging Clinical Results

  2016cited by this paper
• The therapeutic monoclonal antibody market

  2015cited by this paper
• Exploiting light chains for the scalable generation and platform purification of native human bispecific IgG

  2015cited by this paper
• Bispecific antibodies.

  2015cited by this paper
• A novel, native-format bispecific antibody triggering T-cell killing of B-cells is robustly active in mouse tumor models and cynomolgus monkeys

  2015cited by this paper
• Bispecific antibodies and their applications

  2015cited by this paper
• What's fueling the biotech engine—2012 to 2013

  2014cited by this paper
• Human Antibody Production in Transgenic Animals

  2014cited by this paper
• Generation of bispecific IgG antibodies by structure-based design of an orthogonal Fab interface

  2014cited by this paper
• Antibody Engineering

  2014cited by this paper
• The history of monoclonal antibody development – Progress, remaining challenges and future innovations

  2014cited by this paper
• Mutational approaches to improve the biophysical properties of human single-domain antibodies.

  2014cited by this paper
• Signaling by epithelial members of the CEACAM family – mucosal docking sites for pathogenic bacteria

  2014cited by this paper
• Structural insights and biomedical potential of IgNAR scaffolds from sharks

  2014cited by this paper
• Nanobodies: natural single-domain antibodies.

  2013cited by this paper
• High-Affinity IgG Antibodies Develop Naturally in Ig-Knockout Rats Carrying Germline Human IgH/Igκ/Igλ Loci Bearing the Rat CH Region

  2013cited by this paper
• Human antibody expression in transgenic rats: comparison of chimeric IgH loci with human VH, D and JH but bearing different rat C-gene regions.

  2013influential reference
• Progress in overcoming the chain association issue in bispecific heterodimeric IgG antibodies

  2012cited by this paper
• World Bispecific Antibody Summit, September 27–28, 2011, Boston, MA

  2012cited by this paper
• Therapeutic assessment of SEED: a new engineered antibody platform designed to generate mono- and bispecific antibodies.

  2011cited by this paper
• Immunoglobulin domain crossover as a generic approach for the production of bispecific IgG antibodies

  2011cited by this paper
• Development of a Two-part Strategy to Identify a Therapeutic Human Bispecific Antibody That Inhibits IgE Receptor Signaling*

  2010cited by this paper
• An improved yeast transformation method for the generation of very large human antibody libraries.

  2010cited by this paper
• SEEDbodies: fusion proteins based on strand-exchange engineered domain (SEED) CH3 heterodimers in an Fc analogue platform for asymmetric binders or immunofusions and bispecific antibodies.

  2010influential reference
• Development trends for human monoclonal antibody therapeutics

  2010cited by this paper
• Directed evolution of a secretory leader for the improved expression of heterologous proteins and full‐length antibodies in Saccharomyces cerevisiae

  2009cited by this paper
• Knockout Rats via Embryo Microinjection of Zinc-Finger Nucleases

  2009cited by this paper
• Bispecific T-cell engaging antibodies for cancer therapy.

  2009cited by this paper
• Antigen selection from an HIV-1 immune antibody library displayed on yeast yields many novel antibodies compared to selection from the same library displayed on phage.

  2007cited by this paper
• Yeast mating for combinatorial Fab library generation and surface display

  2004cited by this paper
• Domain antibodies: proteins for therapy.

  2003cited by this paper
• Bispecific human IgG by design.

  2001cited by this paper
• Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities.

  2000cited by this paper
• An efficient route to human bispecific IgG

  1998cited by this paper
• Yeast surface display for screening combinatorial polypeptide libraries

  1997cited by this paper
• 'Knobs-into-holes' engineering of antibody CH3 domains for heavy chain heterodimerization.

  1996cited by this paper
• Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA.

  1995cited by this paper
• VH shuffling can be used to convert an Fv fragment of anti-hen egg lysozyme specificity to one that recognizes a T cell receptor V alpha.

  1995cited by this paper
• VH shuffling can be used to convert an Fv fragment of anti-hen egg lysozyme specificity to one that recognizes a T cell receptor Vα

  1995cited by this paper
• Preferential species-restricted heavy/light chain pairing in rat/mouse quadromas. Implications for a single-step purification of bispecific antibodies.

  1995cited by this paper
• Rapid cloning by homologous recombination in vivo.

  1993cited by this paper

• T cell engagers: expanding horizons in oncology and beyond

  2025cites this paper
• Targeted dual selection to optimize transposon stable pool generation of multispecifics

  2025cites this paper
• Novel tetravalent bispecific antibody, PSMA/TRAIL-R2 REGULGENT™, induces selective tumor cell apoptosis without hepatotoxicity

  2025cites this paper
• Trispecific SEED antibodies engineered for neutrophil-mediated cell killing

  2025cites this paper
• An Engineered Mouse Model That Generates a Diverse Repertoire of Endogenous, High-Affinity Common Light Chain Antibodies

  2024cites this paper
• Discovery of a common light chain bispecific antibody targeting PD-1 and PD-L1 by Hybridoma-to-Phage-to-Yeast (H2PtY) platform

  2024cites this paper
• Engineering and physicochemical characterization of a novel, stable, symmetric bispecific antibody with dual target‐binding using a common light chain

  2024cites this paper
• Mechanism-Driven Design of Multispecific Antibodies for Targeted Disease Treatment.

  2024cites this paper
• Efficient production of bispecific antibody by FAST-IgTM and its application to NXT007 for the treatment of hemophilia A

  2023cites this paper
• Next generation of multispecific antibody engineering.

  2023cites this paper
• Structure and Dynamics Guiding Design of Antibody Therapeutics and Vaccines

  2023cites this paper
• Conditional activation of an anti-IgM antibody-drug conjugate for precise B cell lymphoma targeting

  2023cites this paper
• Generation of a symmetrical trispecific NK cell engager based on a two-in-one antibody

  2023cites this paper
• A Generic Strategy to Generate Bifunctional Two-in-One Antibodies by Chicken Immunization

  2022influential citation
• Opportunities and challenges of bi-specific antibodies.

  2022cites this paper
• The proximity of the N- and C- termini of bovine knob domains enable engineering of target specificity into polypeptide chains

  2022cites this paper
• Advances in antibody phage display technology.

  2022cites this paper
• CDR loop interactions can determine heavy and light chain pairing preferences in bispecific antibodies

  2022cites this paper
• [Bispecific antibodies: An old story with a bright future… with CAR-T cells!]

  2021cites this paper
• Introduction to Antibody Engineering

  2021cites this paper
• Rational selection of building blocks for the assembly of bispecific antibodies

  2021cites this paper
• Common light chain chickens produce human antibodies of high affinity and broad epitope coverage for the engineering of bispecifics

  2021cites this paper
• Antibody display technologies: selecting the cream of the crop

  2021cites this paper
• Recent Advances in the Molecular Design and Applications of Multispecific Biotherapeutics

  2021cites this paper
• Bioassay Development for Bispecific Antibodies—Challenges and Opportunities

  2021cites this paper
• Constant domain-exchanged Fab enables specific light chain pairing in heterodimeric bispecific SEED-antibodies.

  2020cites this paper
• Bispecific Antibodies

  2020cites this paper
• Antibody Display Systems

  2020cites this paper
• Expeditious Generation of Biparatopic Common Light Chain Antibodies via Chicken Immunization and Yeast Display Screening

  2020cites this paper
• Humanization of Chicken‐Derived scFv Using Yeast Surface Display and NGS Data Mining

  2020cites this paper
• Toward Drug-Like Multispecific Antibodies by Design

  2020cites this paper
• Isolation of Common Light Chain Antibodies from Immunized Chickens Using Yeast Biopanning and Fluorescence‐Activated Cell Sorting

  2020cites this paper
• A novel efficient bispecific antibody format, combining a conventional antigen-binding fragment with a single domain antibody, avoids potential heavy-light chain mis-pairing.

  2020cites this paper
• Engineered Technologies and Bioanalysis of multispecific Antibody Formats

  2020cites this paper
• Isolation of Anti-Hapten Antibodies by Fluorescence-Activated Cell Sorting of Yeast-Displayed B-Cell Receptor Gene Repertoires.

  2020cites this paper
• Isolation of Tailor-Made Antibody Fragments from Yeast-Displayed B-Cell Receptor Repertoires by Multiparameter Fluorescence-Activated Cell Sorting.

  2020cites this paper
• Intein mediated high throughput screening for bispecific antibodies

  2020cites this paper
• LegoBody: facile generation of bispecific and multi-specific antibodies

  2019cites this paper
• Dual Function pH Responsive Bispecific Antibodies for Tumor Targeting and Antigen Depletion in Plasma

  2019influential citation
• A novel one-step approach for the construction of yeast surface display Fab antibody libraries

  2018cites this paper
• An antibody with Fab-constant domains exchanged for a pair of CH3 domains

  2018cites this paper
• Engineering IgG-Like Bispecific Antibodies—An Overview

  2018cites this paper
• Facile generation of antibody heavy and light chain diversities for yeast surface display by Golden Gate Cloning

  2018cites this paper
• A Streamlined Approach for the Construction of Large Yeast Surface Display Fab Antibody Libraries.

  2018cites this paper
• Selection of Antibodies with Tailored Properties by Application of High-Throughput Multiparameter Fluorescence-Activated Cell Sorting of Yeast-Displayed Immune Libraries

  2018cites this paper
• Productive common light chain libraries yield diverse panels of high affinity bispecific antibodies

  2017cites this paper
• Engineering bispecific antibodies with defined chain pairing.

  2017cites this paper